β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis

• 收藏
• 分享

专利权人:

Michele Pagano

发明人:

Michele Pagano,Elinor Dehan

申请号：

US12478003

公开号：

US08093043B2

申请日:

2009.06.04

申请国别(地区):

US

年份:

2012

代理人:

摘要：

The invention relates to modulating BimEL levels (Bcl-2-Interacting Mediator of cell death, Extra Long isoform) to sensitize cancer cells to cell death or apoptosis. In certain embodiments, the invention relates to increasing BimEL levels. In certain embodiments, the invention relates to inhibitors of at least one of β-TrCP1/2 or RSK1/2 proteins that sensitize tumor cells to chemotherapy-induced death or apoptosis. Additionally, the invention relates to cancer therapies, diagnostics, and methods for identifying novel drugs or drug candidates for increasing BimEL levels.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/